About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

An Option for Many High-Risk Individuals: Antiviral Treatments for COVID-19

By: NewsUSA

(NewsUSA) - In the ongoing battle against COVID-19, vaccines have been successful in helping to reduce illness and contributing to the declining numbers of infections in the U.S. and around the world. But COVID-19 is not gone, and it remains a significant threat. Those with weakened immune systems, chronic illnesses and other risk factors are particularly vulnerable to severe illness from the virus.

While vaccines are still the best first defense against COVID-19, antiviral treatments have emerged as another powerful tool to help fight the virus and protect those who face greater risk of severe illness and hospitalization from COVID-19.

Who’s at Risk?

Millions of Americans face a higher risk of developing severe COVID-19, and many may not even know it. Being age 50 or over, or having a host of common health conditions including cancer, asthma, diabetes, heart disease, and weakened immune systems can make someone more likely to experience severe COVID-19 symptoms.

Treatments Are Available

The good news is that, for many of those at high risk who become infected with COVID-19 and have mild to moderate symptoms, antivirals can be a safe and effective treatment option. Antivirals work by helping to stop the virus from making copies of itself. This can help limit the spread of the virus inside the body — minimizing the severity of symptoms and the duration of the illness.

The need for speed is a fundamental principle underlying antiviral treatments for COVID-19. When someone at high risk becomes infected with COVID-19, the virus can spread rapidly within their body, which can cause severe respiratory problems and complications. This is where antiviral treatments may be able to help. Treatment with COVID-19 antivirals is most effective if it starts within the first five to seven days that the first COVID-19 symptoms appear.

But antivirals are not for everyone. They are not recommended for people who are younger, healthy and not at high risk of getting severely ill due to COVID-19, and there are certain health conditions and medications that are known to cause adverse reactions with antiviral treatments. Talk with a healthcare provider to know if an antiviral treatment is an option.

Plan Ahead

For anyone at high risk for severe COVID-19, acting quickly when infection happens, and planning ahead will be key to getting the treatment they may need. Begin by planning:

  • Making a list of current medications,
  • Talking with a healthcare provider to understand the risk for severe COVID-19 and discuss potential treatment options, and
  • Creating a plan to get tested and begin treatment at the first sign of a COVID-19 infection and before the 5–7-day window of opportunity closes.

Why Speed Matters

  • Stop the Virus from Multiplying: The earlier someone starts antiviral treatment, the better chance they have to lower the level of virus in their body, which can make a difference in their recovery.
  • Minimize Severe Symptoms: Quick action can help prevent mild symptoms from turning severe – potentially preventing a hospital stay.
  • Limit the Impact of COVID-19 on Your Life: Speedy treatment can shorten the time you are sick, easing the burden of the virus on your life and getting you back to usual.
  • Helping to Protect Others: High-risk individuals not only face danger themselves but can also unknowingly spread the virus to others. Rapid treatment helps break the chain of transmission.

 

Remember, timing matters in reducing the risks of COVID-19 and planning ahead can make the difference in the lives of those most vulnerable.

Visit covidvaccineproject.org/treatments to make a plan for yourself or someone that matters to you today.

More News

View More
Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally
Via MarketBeat
Tickers AMZN
Let the Good Times Roll: 2 Stocks Showing No Signs of Slowing
Via MarketBeat
Topics Artificial Intelligence World Trade
Tickers ATRO INOD META
Café Culture Revival? 3 Stocks to Watch After Chick-fil-A’s Move
Via MarketBeat
Tickers CMG MCD SBUX YUM
Carmakers Step in With Incentives as EV Tax Credit Expires
Via MarketBeat
Topics Economy Government
Tickers F GM TSLA
Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure
Via MarketBeat
Topics Lawsuit
Tickers ZG
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.